Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy.

Nelson SP, Kothari S, Wu EQ, Beaulieu N, McHale JM, Dabbous OH.

J Med Econ. 2009;12(4):348-55. doi: 10.3111/13696990903378680.

PMID:
19827992
2.

Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.

Kothari S, Nelson SP, Wu EQ, Beaulieu N, McHale JM, Dabbous OH.

Curr Med Res Opin. 2009 Nov;25(11):2703-9. doi: 10.1185/03007990903307755.

PMID:
19775195
3.

In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events.

López-Sendón J, Dabbous OH, López de Sá E, Stiles M, Gore JM, Brieger D, van de Werf F, Budaj A, Gurfinkel EP, Fox KA; GRACE Investigators.

Rev Esp Cardiol. 2009 May;62(5):501-9. English, Spanish.

4.

Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.

Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A; GRACE Investigators.

Arch Intern Med. 2009 Feb 23;169(4):402-9. doi: 10.1001/archinternmed.2008.572.

PMID:
19237725
5.

Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events.

Nallamothu B, Fox KA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA; GRACE Investigators.

Heart. 2007 Dec;93(12):1552-5. Epub 2007 Jun 25.

6.

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.

Dabbous OH, Anderson FA Jr, Gore JM, Eagle KA, Fox KA, Mehta RH, Goldberg RJ, Agnelli G, Steg PG; GRACE Investigators.

Heart. 2008 Feb;94(2):159-65. Epub 2007 Jun 17.

PMID:
17575335
7.

Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).

Brieger D, Van de Werf F, Avezum A, Montalescot G, Kennelly BM, Granger CB, Goodman SG, Dabbous OH, Agnelli G; GRACE Investigators.

Am Heart J. 2007 Jun;153(6):960-9.

PMID:
17540196
8.
9.

Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification.

Oliveira GB, Avezum A, Anderson FA Jr, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KA, Gore JM, Granger CB; GRACE Investigators.

Am Heart J. 2007 Apr;153(4):493-9.

PMID:
17383284
10.

Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events.

Emery M, López-Sendón J, Steg PG, Anderson FA Jr, Dabbous OH, Scheuble A, Eagle KA; GRACE Investigators.

Am Heart J. 2006 Dec;152(6):1015-21.

PMID:
17161045
11.

Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.

Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA Jr; GRACE Investigators.

Int J Cardiol. 2007 Jun 25;119(1):65-72. Epub 2006 Oct 12.

PMID:
17045681
12.

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).

Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB.

BMJ. 2006 Nov 25;333(7578):1091. Epub 2006 Oct 10.

13.

Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE).

Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D; GRACE investigators.

Heart. 2007 Feb;93(2):177-82. Epub 2006 Jun 6.

14.

Image-guided resection of high-grade glioma: patient selection factors and outcome.

Litofsky NS, Bauer AM, Kasper RS, Sullivan CM, Dabbous OH; Glioma Outcomes Project Investigators.

Neurosurg Focus. 2006 Apr 15;20(4):E16.

PMID:
16709021
15.

Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.

Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, Collet JP, Dabbous OH, Henry P, Carruthers KF, Dauphin A, Arguelles CS, Masliah J, Hugel B, Montalescot G, Freyssinet JM, Asselain B, Tedgui A.

J Am Coll Cardiol. 2005 Oct 4;46(7):1249-57.

16.

Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).

Lim MJ, Eagle KA, Gore JM, Anderson FA Jr, Dabbous OH, Mehta RH, Granger CB, Fox KA, Spencer FA, Goldberg RJ; Global Registry of Acute Coronary Events Investigators.

Am J Cardiol. 2005 Oct 1;96(7):917-21.

PMID:
16188516
17.

In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score.

Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman SG; Canadian Acute Coronary Syndromes Registry Investigators.

Am J Cardiol. 2005 Oct 1;96(7):913-6.

PMID:
16188515
18.

Medication performance measures and mortality following acute coronary syndromes.

Granger CB, Steg PG, Peterson E, López-Sendón J, Van de Werf F, Kline-Rogers E, Allegrone J, Dabbous OH, Klein W, Fox KA, Eagle KA; GRACE Investigators.

Am J Med. 2005 Aug;118(8):858-65.

PMID:
16084178
19.

Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events.

Budaj A, Flasinska K, Gore JM, Anderson FA Jr, Dabbous OH, Spencer FA, Goldberg RJ, Fox KA; GRACE Investigators.

Circulation. 2005 Jun 21;111(24):3242-7. Epub 2005 Jun 13.

PMID:
15956123
20.

Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational global registry of acute coronary events.

Montalescot G, Dabbous OH, Lim MJ, Flather MD, Mehta RH; Global Registry of Acute Coronary Events Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1397-403.

PMID:
15950559
21.

Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry.

Devlin G, Anderson FA, Heald S, López-Sendón J, Avezum A, Elliott J, Dabbous OH, Brieger D; GRACE Investigators.

Heart. 2005 Nov;91(11):1394-9. Epub 2005 Mar 10.

22.

Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.

Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH; GRACE Investigators.

Eur Heart J. 2005 Jun;26(11):1063-9. Epub 2005 Feb 16.

PMID:
15716281
23.

Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE).

Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, Macleod D, Fox KA; GRACE Investigators.

Heart. 2005 Mar;91(3):290-8.

24.

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA; GRACE Investigators.

JAMA. 2004 Jun 9;291(22):2727-33.

PMID:
15187054
25.

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, López-Sendón J, Budaj A, Goldberg RJ, Klein W, Anderson FA Jr; Global Registry of Acute Coronary Events Investigators.

Circulation. 2004 Feb 3;109(4):494-9. Epub 2004 Jan 26.

PMID:
14744970
26.

Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE).

Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, López-Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ; GRACE Investigators.

Am Heart J. 2004 Jan;147(1):42-8.

PMID:
14691417
27.

Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).

Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, Avezum A, Cannon CP, Mazurek T, Flather MD, Van De Werf F; GRACE Investigators.

Am Heart J. 2003 Dec;146(6):999-1006.

PMID:
14660991
28.

Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation.

Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KA, Gore JM, Goldberg RJ, Eagle KA; GRACE Investigators.

Am J Cardiol. 2003 Nov 1;92(9):1031-6.

PMID:
14583352
29.

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE).

Fox KA, Goodman SG, Anderson FA Jr, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM; GRACE Investigators.

Eur Heart J. 2003 Aug;24(15):1414-24.

PMID:
12909070
30.

T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation.

Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ.

Lancet. 2003 Jul 12;362(9378):125-6.

PMID:
12867114

Supplemental Content

Loading ...
Support Center